SEPTIN9 and colorectal carcinoma: In CRC, a blood‐based test based on real‐time MSP detection of methylated Septin9 in DNA obtained from peripheral blood samples has been FDA‐approved for early detection; however, a positive result should still be verified by colonoscopy or sigmoidoscopy [17].